CARIBOU BIOSCIENCES
Caribou Biosciences is a operator of a medical technology company intended to analyze cell and genome engineering. The company specializes in cellular engineering and analysis based on the CRISPR-Cas9 technology platform which paired with a guide RNA, cuts double-stranded DNA and allows for specific changes to DNA, enabling development of therapeutics for agricultural biotechnology, industrial biotechnology and basic and applied biological research.
CARIBOU BIOSCIENCES
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.cariboubio.com
Total Employee:
101+
Status:
Active
Contact:
510-982-6030
Email Addresses:
[email protected]
Total Funding:
167.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Font Awesome Domain Not Resolving Apache
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Ikena Oncology
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
LifeSci Venture Partners
LifeSci Venture Partners investment in Series C - Caribou Biosciences
Avego Bioscience Capital
Avego Bioscience Capital investment in Series C - Caribou Biosciences
Maverick Ventures
Maverick Ventures investment in Series C - Caribou Biosciences
Ridgeback Capital
Ridgeback Capital investment in Series C - Caribou Biosciences
Farallon Capital Management
Farallon Capital Management investment in Series C - Caribou Biosciences
Avidity Partners
Avidity Partners investment in Series C - Caribou Biosciences
Janus Henderson Investors
Janus Henderson Investors investment in Series C - Caribou Biosciences
Adage Capital Management
Adage Capital Management investment in Series C - Caribou Biosciences
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series C - Caribou Biosciences
Heritage Group
Heritage Group investment in Series C - Caribou Biosciences
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2014-11-18 | Intellia Therapeutics | Caribou Biosciences investment in Series A - Intellia Therapeutics | 15 M USD |
Key Employee Changes
Date | New article |
---|---|
2020-05-15 | Cherry Thomas joins Caribou as SVP of clinical development; Artax locks in Joseph Lobacki as CEO |
Official Site Inspections
http://www.cariboubio.com Semrush global rank: 3.31 M Semrush visits lastest month: 4.88 K
- Host name: ec2-34-192-255-123.compute-1.amazonaws.com
- IP address: 34.192.255.123
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149